Practice
Featured experience
Litigation victory for Novo Nordisk on insulin pricing
After six years of litigation, the plaintiffs voluntarily dismissed their case with no recovery of any kind
Complete dismissal of shareholder litigation brought against MoneyLion
We secured dismissal of all claims brought against MoneyLion and its directors and officers
Ninth Circuit affirms dismissal for Lucid Motors, limits Section 10(b) standing
We secured a complete victory for Lucid
Victory for Morgan Stanley on the eve of trial in longstanding RMBS case
We secured a victory for Morgan Stanley in the last of its financial crisis-era cases
Citigroup wins complete dismissal of qui tam suit alleging tax fraud
Davis Polk recently achieved a major victory for its client, Citigroup Inc. On May 30, 2017, Justice Charles Ramos of the…
Davis Polk Advises the Special Committee of Ormat in Connection with the Acquisition by ORIX of an Ownership Stake in Ormat from FIMI and Bronicki Investments
Davis Polk is advising the special committee of the board of directors of Ormat Technologies, Inc. in connection with the…
Davis Polk Wins Dismissal of RMBS Action for Morgan Stanley
On April 12, 2017, Justice Ramos of the New York Supreme Court, Commercial Division, dismissed with prejudice four…
Appeals Court Affirms Davis Polk Win on Motion to Dismiss for Castleton Commodities
On March 16, 2017 a New York appellate court in Manhattan affirmed a ruling dismissing claims against Davis Polk’s client,…
Appeals Court Affirms Summary Judgment Victory for Morgan Stanley
On March 15, 2017, the Appellate Division of the Supreme Court of the State of New York, First Judicial Department affirmed…
Davis Polk Advises Fortress Investment Group’s Special Committee on Its Acquisition by SoftBank
Davis Polk is advising the Special Committee of Independent Directors of Fortress Investment Group LLC in connection with…
Davis Polk Victory in Facebook IPO Litigation
On November 3, 2016, the Second Circuit issued an opinion in an action brought under Section 16(b) of the Exchange Act of…
Davis Polk Advises OneMain on the Sale of Its Interest in SpringCastle
Davis Polk advised the special committee of the board of directors of OneMain Holdings, Inc. in connection with the sale of…
First Wind Holdings resolution of commercial disputes
We successfully resolved several disputes on behalf of the wind energy company
Bio-Reference Laboratories $1.47 billion acquisition by OPKO Health
Davis Polk is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by…